This Weight-Loss Stock Sank After Earnings. It’s Still a Risk for Eli Lilly, Novo Nordisk. – Barron’s By Weight Loss Haven This Weight-Loss Stock Sank After Earnings. It’s Still a Risk for Eli Lilly, Novo Nordisk. Barron’s Brought to you by Google News. Read the rest of the article here Facebook Twitter Pinterest